Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction.
Saved in:
| Title: | Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction. |
|---|---|
| Authors: | Sullivan R; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada., Hou J; Lakehead University and Thunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada., Yu L; London Regional Cancer Program, London, Ontario, Canada., Wilk B; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Sykes J; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada., Biernaski H; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada., Butler J; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada., Kovacs M; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Hicks J; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Thiessen JD; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Dharmakumar R; Indiana School of Medicine, Indianapolis, Indiana; and., Prato FS; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Wisenberg G; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada., Luyt LG; London Regional Cancer Program, London, Ontario, Canada.; Departments of Chemistry, Oncology, and Medical Imaging, Western University, London, Ontario, Canada., Dhanvantari S; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada; sdhanvan@lawsonimaging.ca.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1633-1639. Date of Electronic Publication: 2024 Oct 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
